free性video西欧极品,伊人依成久久人综合网,中文字幕人妻一区二区三区熟女,男女高潮激烈无遮挡免费观软件 ,成人3d动漫一区二区三区

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

EU drug regulator records 415 cases of possible rare blood clotting

firstwordpharmaJune 18, 2021

Tag: AstraZeneca , Johnson & Johnson , COVID-19 , vaccine

The EU drug regulator said on Thursday it has received reports of 415 possible cases of thrombosis with thrombocytopenia syndrome in the European Economic Area (EEA), out of over 50 million people who have gotten AstraZeneca and Johnson & Johnson's COVID-19 vaccines, as reported in Fidelity.

EU drug regulator records 415 cases of possible rare blood clotting

Specifically, there have been 10 possible cases among just under 6 million people who received Johnson & Johnson's shot in the EEA, and 405 cases among 45 million who received AstraZeneca's shot, stated Georgy Genov, head of pharmacovigilance at the European Medicines Agency.


Previous:Alzamend Neuro Announces Closing of Initial Public Offering and Full Exercise of Underwriter’s Over-allotment Option for Gross Proceeds of $14.4 Million

Next:U.S. Buys 200 Million Extra Moderna Vaccine Doses, as Possible Booster Shots

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service